Editorial Offices
5635 Fishers Lane, Suite 6000
Rockville, MD 20852
Tel: 877-524-9336
Email: fpnews@elsevier.com
Advertising Offices
60 Columbia Rd., Bldg. B
Morristown, NJ 07960
Tel: 973-290-8200
Fax: 973-290-8250
Sales Director
Mark Altier
Tel: 973-290-8220
Email: m.altier@elsevier.com
Sales Manager
Phil Soufleris
Tel: 973-290-8224
Email: p.soufleris@elsevier.com
National Account Managers
Kathleen Hiltz
Tel: 973-290-8219
Email: k.hiltz@elsevier.com
Peter Messina
Tel: 973-290-8221
Email: p.messina@elsevier.com
Address Changes
Fax change of address (with old mailing label) to 973-290-8245 or e-mail change to subs@elsevier.com.
Licensing/Reprints/Eprints:
Nick Iademarco
Sales Manager
Wright's Media
2407 Timberloch Place
Suite B
The Woodlands, Texas 77386
Toll Free: 877-652-5295, ext. 102
Fax: 281-419-5712
Email: niademarco@wrightsmedia.com
www.wrightsmedia.com
Last updated August 30, 2011
Specialty Focus
Cancer
Cardiovascular Disease
Child & Adolescent Medicine
Diabetes, Endocrinology & Metabolism
Digestive Disorders
Geriatric Medicine
Kidney Diseases
Men's Health
Mental Health
Musculoskeletal Disorders
Neurologic Disorders
Obesity
Practice Trends
Pulmonary & Sleep Disorders
Skin Disorders
Women's Health
| May 11 - 21 Departs Civitavecchia, | Rheumatology and Orthopaedics |
| May 11 - 21 Departs Civitavecchia, | Rheumatology and Orthopaedics |
| May 12 - 21 Departs Oslo, | Pain Management/Neurology/Compliance |
| May 13 - 17 Harrogate, | Royal College of Nursing (RCN): Annual Congress |
| May 15 - 17 Liverpool, | Royal College of Ophthalmologists: Congress 2012 |
| May 15 - 18 Paris, | European Association of Percutaneous Cardiovascular Interventions (EAPCI): EuroPCR |
| May 16 - 19 Melbourne, | World Federation for NeuroRehabilitation (WFNR): 7th World Congress of Neurorehabilitation (WCNR2012) |
| May 16 - 19 Denver, CO | Pediatric Orthopaedic Society of North America (POSNA): Annual Meeting |
| May 16 - 19 Honolulu, HI | American Pain Society (APS): Annual Scientific Meeting |
| May 16 - 20 Marrakesh, | 8th Metabolic Syndrome, type II Diabetes and Atherosclerosis Congress |